Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease
Catheterization and Cardiovascular Interventions Aug 18, 2017
Takagi H, et al. – A meta–analysis was carried out to probe into the comparative efficacy of percutaneous coronary intervention with drug–eluting stents (DES–PCI) versus coronary artery bypass grafting (CABG) for left–main coronary artery disease (LMCAD). Findings revealed that DES–PCI versus CABG was related to increases in repeat revascularization (RRV) and the composite of death, myocardial infarction (MI), and RRV (with/without stroke), despite no differences in mortality, MI, stroke, and the composite of death and MI (with/without stroke).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries